ZBTB34 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.323900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.330780E-01
Normal-vs-Stage2
5.080300E-02
Normal-vs-Stage3
4.647600E-02
Normal-vs-Stage4
4.772000E-01
Stage1-vs-Stage2
9.570200E-01
Stage1-vs-Stage3
1.993370E-01
Stage1-vs-Stage4
5.885200E-01
Stage2-vs-Stage3
1.288560E-01
Stage2-vs-Stage4
4.624000E-01
Stage3-vs-Stage4
1.976960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.058200E-02
Normal-vs-AfricanAmerican
9.632000E-02
Normal-vs-Asian
2.741000E-01
Caucasian-vs-AfricanAmerican
6.848600E-01
Caucasian-vs-Asian
4.669600E-01
AfricanAmerican-vs-Asian
5.214200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.449600E-02
Normal-vs-Female
4.024300E-02
Male-vs-Female
6.489200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.829170E-01
Normal-vs-Age(41-60Yrs)
1.710440E-01
Normal-vs-Age(61-80Yrs)
2.685800E-02
Normal-vs-Age(81-100Yrs)
3.760600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.133600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.453600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.230000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.822300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.562200E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.677420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.664300E-02
Normal-vs-Daily Drinker
5.214100E-02
Normal-vs-Weekly Drinker
1.161160E-01
Normal-vs-Occasional Drinker
1.694080E-02
Normal-vs-Social Drinker
5.262100E-02
Non Drinker-vs-Daily Drinker
9.503400E-01
Non Drinker-vs-Weekly Drinker
6.693000E-01
Non Drinker-vs-Occasional Drinker
4.745800E-01
Non Drinker-vs-Social Drinker
3.703600E-01
Daily Drinker-vs-Weekly Drinker
7.195000E-01
Daily Drinker-vs-Occasional Drinker
5.538600E-01
Daily Drinker-vs-Social Drinker
4.108400E-01
Weekly Drinker-vs-Occasional Drinker
9.351000E-01
Weekly Drinker-vs-Social Drinker
7.190600E-01
Occasional Drinker-vs-Social Drinker
6.806800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.524050E-01
Normal-vs-Grade 2
2.865900E-02
Normal-vs-Grade 3
5.868200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.672570E-01
Grade 1-vs-Grade 3
3.566600E-01
Grade 1-vs-Grade 4
1.524050E-01
Grade 2-vs-Grade 3
7.411200E-01
Grade 2-vs-Grade 4
2.865900E-02
Grade 3-vs-Grade 4
5.868200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.883930E-02
Normal-vs-NonDiabetic
4.949800E-02
Diabetic-vs-NonDiabetic
1.958390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.162500E-02
Normal-vs-NoPancreatitis
3.716200E-02
Pancreatitis-vs-NoPancreatitis
8.092000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.434300E-02
Normal-vs-N1
5.802400E-02
N0-vs-N1
3.124800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.036980E-01
Normal-vs-TP53-NonMutant
4.251700E-02
TP53-Mutant-vs-TP53-NonMutant
2.683600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
